Sustained High Efficacy and Favorable Safety Over Five Years in Patients With Burdensome Psoriasis (UNCOVER-1/UNCOVER-2)

August 2021 | Volume 20 | Issue 8 | Original Article | 880 | Copyright © August 2021


Published online August 1, 2021

Kim A. Papp MD PhD FRCPC,a Sascha Gerdes MD,b Craig L. Leonardi MD,c Hany Elmaraghy MD,d Kyoungah See MS,d Missy McKean-Matthews MS,d Bruce W. Konicek MS,d Heidi M. Crane MD,d William Eastman MDd

aProbity Medical Research and K. Papp Clinical Research, Waterloo, Ontario, Canada
bPsoriasis-Center at the Department of Dermatology, University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Germany
cCentral Dermatology, St Louis, MO DEli Lilly and Company, Indianapolis, IN
dEli Lily and Company, Indianapolis, IN